Supplement Library
FULL SUPPLEMENT: The New Landscape of Field Cancerization: Proven Efficacy Without Severe Skin Reactions
July 2025 | Volume 24 | Issue 7 | Department | 19911s1 | Copyright © July 2025
Actinic keratosis (AK) is a precancerous lesion that occurs with greatest frequency in individuals aged 60 or older and in men. Given the role of chronic UV exposure in engendering these lesions, they...
Read MoreINDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes
July 2025 | Volume 24 | Issue 7 | Supplement Individual Articles | 19912s5 | Copyright © July 2025
Actinic keratosis (AK) is a skin lesion that arises due to chronic sun exposure. Treatment of all AKs is recommended due to their risk of progressing to squamous cell carcinomas (SCCs). Many fiel...
Read MoreINDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis
July 2025 | Volume 24 | Issue 7 | Supplement Individual Articles | 19913s13 | Copyright © July 2025
Actinic keratosis (AK) is a common, precancerous skin lesion that may progress to squamous cell carcinoma (SCC). Traditional topical therapies for AKs often require long treatment durations. Thes...
Read MoreINDIVIDUAL ARTICLE: An Algorithm Integrating Acneceuticals Into the Management of Acne Vulgaris
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08423s13 | Copyright © June 2025
Background: Acne vulgaris is a common, chronic cutaneous disorder with numerous efficacious prescription and procedural treatments. Therapy, however, is hampered by medication in...
Read MoreINDIVIDUAL ARTICLE: The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08422s4 | Copyright © June 2025
Background: Acne is a multifactorial inflammatory skin condition that commonly presents to the dermatology clinic. Treatment generallyinvolves the use of pharmaceuti...
Read MoreFULL SUPPLEMENT: Acneceuticals maximized therapeutic outcomes in a real-world setting
June 2025 | Volume 24 | Issue 6 | Department | 08420s1 | Copyright © June 2025
In this issue:
The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature
Acne is the most common cutaneous disease worldwi...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08421s19 | Copyright © June 2025
Background: Acne vulgaris is a common, multifactorial inflammatory skin disease for which there are many pharmacologic and procedural interventions. Recent publications have stre...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom 6): A Practical Algorithm Integrating Skincare for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
May 2025 | Volume 24 | Issue 5 | Department | 49630s1 | Copyright © May 2025
INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
May 2025 | Volume 24 | Issue 5 | Supplement Individual Articles | 49631s3 | Copyright © May 2025
Introduction: Hormonal therapies, typically used in the treatment of breast and prostate cancer patients, have been associated with numerous skin toxicities that can impact quality...
Read MoreFULL SUPPLEMENT: Defining and Treating Pre-Aging With a Novel Multi-Functional Cosmetic Peptide, Acetyl Dipeptide-31 Amide
May 2025 | Volume 24 | Issue 5 | Department | 51180s1 | Copyright © May 2025
INDIVIDUAL ARTICLE: A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide (AP31)
May 2025 | Volume 24 | Issue 5 | Supplement Individual Articles | 51181s4 | Copyright © May 2025
Background: Patients experiencing signs of pre-aging in their 20s and early 30s desire solutions including topical skincare and cosmetic procedures to help preserve skin quality an...
Read MoreFULL SUPPLEMENT: Incorporating Cosmeceuticals in In-Office Aesthetic Procedures for Skin of Color
April 2025 | Volume 24 | Issue 4 | Department | 41490s1 | Copyright © April 2025
Common signs of skin aging include wrinkles, fine lines, and pigmentary disorders. Patients with skin of color present with unique dermatologic challenges due to differences in how skin conditions man...
Read MoreINDIVIDUAL ARTICLE: Breaking Barriers: Advancing Cosmeceuticals and Integrated Skincare for Skin of Color
April 2025 | Volume 24 | Issue 4 | Supplement Individual Articles | 41491s5 | Copyright © April 2025
Common signs of skin aging include wrinkles, fine lines, and pigmentary disorders. Patients with skin of color present with unique dermatologic challenges due to differences in how skin condition...
Read MoreFULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM ) V: A Multidisciplinary-Guided Algorithm for Preventing and Managing Cutaneous Hormonal Therapy-Related Adverse Events in Cancer Patients
April 2025 | Volume 24 | Issue 4 | Department | 84820s1 | Copyright © April 2025
Although cancer incidence continues to rise, advancements in treatment options have contributed to the decline in cancer mortality.1,3 Hormonal therapy is a mainstay treatment for the management of ho...
Read MoreINDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
April 2025 | Volume 24 | Issue 4 | Supplement Individual Articles | 84821s3 | Copyright © April 2025
Introduction: In 2024, over 2 million patients will be diagnosed with cancer in the United States, with prostate cancer and breast cancer representing the leading diagnoses in me...
Read MoreFULL SUPPLEMENT: Exploring The Scalp Barrier and Microbiome In Diverse Dandruff Patients
March 2025 | Volume 24 | Issue 3 | Department | 32730s1 | Copyright © March 2025
Although the exact pathophysiology of dandruff is still not completely decoded, current theories highlight the role of the microbiome on the skin surface in the patho-genesis. Several scalp microbiome...
Read MoreINDIVIDUAL ARTICLE: A Clinical Evaluation of Scalp Barrier Function, Ceramide Levels, and Microbiome in Diverse Dandruff Patients
March 2025 | Volume 24 | Issue 3 | Supplement Individual Articles | 32731s3 | Copyright © March 2025
Dandruff is a common chronic scalp condition that affects approximately half the population irrespective of their origin. Dandruff scalps are characterized by flaking skin, pruritus, and minimal ...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom) 5: A Practical Algorithm for the Treatment And Supportive Management of Cutaneous Adverse Events in Patients Receiving Targeted Therapy for Cancer
March 2025 | Volume 24 | Issue 3 | Department | 88540s1 | Copyright © March 2025
Although cancer incidences seemingly continue to rise, ongoing advancements in cancer therapy have simultaneously contributed to improved survival. Nordic survival studies from the past decades have s...
Read MoreINDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events
March 2025 | Volume 24 | Issue 3 | Supplement Individual Articles | 88541s3 | Copyright © March 2025
Background: The cancer burden in the Nordic European countries remains substantial, but new treatment approaches, such as targeted therapy, have increased the survival of cancer ...
Read MoreFULL SUPPLEMENT: Scalp Health & the Role of the Scalp Barrier in Dandruff and Seborrheic Dermatitis
February 2025 | Volume 24 | Issue 2 | Department | 32710 | Copyright © February 2025
Research has shown that scalp and hair health are connected, but the link is not yet fully understood or characterized. Hair growth begins within the hair follicle, about 4 mm deep in the skin.1<...
Read More